Lactococcus Lactis for Lactose Intolerance

Research suggests that Lactococcus lactis, particularly strains engineered to produce or secrete the enzyme β-galactosidase, may offer a promising approach for managing lactose intolerance by enhancing lactose digestion in the gut. Studies indicate that modified strains have demonstrated functional lactose-breaking activity in laboratory settings, and one mouse study found that oral administration of an engineered strain reduced digestive distress symptoms, though the benefit appeared to stem from favorable shifts in gut microbiome composition rather than direct enzymatic activity alone. Additional research has explored conjugation-based methods to transfer lactose-digesting capabilities to probiotic bacteria without creating genetically modified organisms, and several studies have worked toward developing food-grade versions of these engineered strains by removing antibiotic resistance genes, addressing a key safety concern for real-world application. However, the available evidence consists entirely of preclinical studies — laboratory experiments and animal models — with no human clinical trials identified, which means it is not yet possible to draw conclusions about safety or effectiveness in people, and significant translational work remains before these approaches could be considered for practical use.